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Control of chronic viral infections by CD8 T cells is
critically dependent on CD4 help. In particular, help-
er-derived IL-21 plays a key role in sustaining the
CD8 T cell response; however, the molecular path-
ways by which IL-21 sustains CD8 T cell immunity
remain unclear. We demonstrate that IL-21 causes
a phenotypic switch of transcription factor expres-
sion in CD8 T cells during chronic viral infection
characterized by sustained BATF expression. Impor-
tantly, BATF expression during chronic infection is
both required for optimal CD8 T cell persistence
and anti-viral effector function and sufficient to
rescue ‘‘unhelped’’ CD8 T cells. Mechanistically,
BATF sustains the response by cooperating with
IRF4, an antigen-induced transcription factor that is
also critically required for CD8 T cell maintenance,
to preserve Blimp-1 expression and thereby sustain
CD8 T cell effector function. Collectively, these data
suggest that CD4 T cells ‘‘help’’ the CD8 response
during chronic infection via IL-21-induced BATF
expression.
INTRODUCTION
Chronic viral infections, such as HIV-1 and hepatitis C virus
(HCV), affect hundreds of millions of people worldwide (Virgin
et al., 2009). Viral persistence is usually associated with T cell
exhaustion, a progressive differentiation process that is charac-
terized by diminished T cell survival and effector functions (Vir-
gin et al., 2009; Wherry, 2011). Early during chronic infection
with the persistent Clone 13 (Cl13) variant of lymphocytic cho-
riomeningitis virus (LCMV) in mice, virus-specific effector CD81118 Cell Reports 13, 1118–1124, November 10, 2015 ª2015 The AuT cells clonally expand normally and are phenotypically equiva-
lent to their counterparts in an acute infection (Brooks et al.,
2006; Doering et al., 2012; Fuller and Zajac, 2003). However,
as chronic infection progresses, virus-specific CD8 T cells grad-
ually lose the ability to produce important effector molecules,
such as interferon gamma (IFN-g), tumor necrosis factor alpha
(TNF-a), and interleukin-2 (IL-2), and concomitantly upregulate
multiple inhibitory surface molecules, including programmed
cell death protein 1 (PD-1), LAG-3, CD160, and 2B4 (Barber
et al., 2006; Blackburn et al., 2009; Wherry, 2011). Neverthe-
less, ‘‘exhausted’’ CD8 T cells are indispensable, because
they retain sufficient function to limit viral replication such that
even transient CD8 T cell depletion causes a substantial rise
in viral load (Jin et al., 1999; Letvin and Walker, 2003; Schmitz
et al., 1999).
The outcome of chronic viral infection also greatly depends on
the quantity and quality of CD4 T cells. A vigorous CD4 T cell
response often correlates with better viral control in HIV patients
and spontaneous recovery in HCV and hepatitis B virus-infected
individuals, whereas decreased CD4 T cell number or function is
tightly associated with failure of viral eradication and disease
progression (Porichis and Kaufmann, 2011; Rehermann and
Nascimbeni, 2005; Virgin and Walker, 2010). Besides direct
killing of infected cells, CD4 T cells provide critical help to B
cell- and CD8 T cell-mediated antiviral responses. In the
absence of CD4 help (i.e., deletion or severe reduction of CD4
T cells), exhausted CD8 T cells develop greater dysfunction
and lose the ability to contain virus (Battegay et al., 1994;Matlou-
bian et al., 1994; Zajac et al., 1998). Recent studies have
elegantly shown that IL-21, produced mainly by CD4 T cells,
enhances CD8 T cell-mediated control of persistent viruses
(Elsaesser et al., 2009; Fro¨hlich et al., 2009; Yi et al., 2009).
Nevertheless, how IL-21 and its downstream signaling and
genetic pathways regulate effector CD8 T cell differentiation
and effector function remains poorly defined. Here, we report
that IL-21-induced basic leucine zipper transcription factor,thors
Figure 1. IL-21 Sustains Effector CD8 T Cell
Function and BATF Expression
(A) IL-21-tRFP reporter mice were infected with
LCMV Arm or Cl13. The frequency of IL-21-ex-
pressingCD4 T cells was examined at day 5, 8, and
21 p.i. and shown in representative contour plots.
(B) Il21+/+ and Il21/ mice were infected with
LCMV Cl13, and splenocytes from day 5- and day
10-infected mice were stimulated in vitro with
GP33, NP396, and GP276 peptides. Bar graphs
show the frequency of IFN-g+CD107a+ effector
CD8+ T cells in Il21+/+ and Il21/mice at day 5 and
10 p.i.
(C and D) The representative histograms show the
expression of granzyme B, Blimp-1, BATF, and
IRF4 in LCMV-specific CD8 T cells from Il21/
(black open) and Il21+/+ (gray solid) mice at day 5
and 10 p.i. Mean fluorescence intensity (MFI)
(mean ± SEM) is shown in the top-right corner.
(E) In vitro activated WT (Stat3+/+) and conditional
deletion of Stat3 (Stat3CKO) CD8 T cells were
treated with IL-21 or vehicle control overnight. The
representative histograms showed the expression
of granzyme B, Blimp-1, BATF, and IRF4 on
Stat3+/+ and Stat3CKO cells. Results are represen-
tative of three independent experiments (n = 6 for
IL-21+/+ and n = 6 for IL-21/). Data are presented
as mean ± SEM.ATF-like (BATF), expression is critically required to sustain anti-
viral function of CD8 T cells during chronic infection.
RESULTS
IL-21 Sustains Effector CD8 T Cell Function and BATF
Expression
To understand the interplay between CD4 and CD8 T cells, we
used IL-21 turbo red fluorescent protein (IL-21-tRFP) knockin
reporter mice (Shulman et al., 2014) to examine the production
of IL-21, a critical CD4-derived cytokine that sustains CD8
T cell response during chronic viral infection (Elsaesser et al.,
2009; Fro¨hlich et al., 2009; Yi et al., 2009). Concurrent with
the rapid loss of IL-2-producing CD4 T cells, as reported pre-
viously (Brooks et al., 2005; Crawford et al., 2014; Fuller and
Zajac, 2003; Oxenius et al., 1998), IL-21-expressing CD4
T cells began to emerge around day 5 and continuously
increased at later phases of chronic infection with LCMVCell Reports 13, 1118–1124, NoCl13 (Figures 1A and S1A). In contrast,
acute infection with the LCMV Arm-
strong (Arm) strain only led to a transient
induction of IL-21 around day 5–8 post-
infection (p.i.) (Figure 1A). To dissect the
temporal effects of CD4-derived IL-21
on CD8 T cell differentiation, we infected
Il21+/+ and Il21/ mice with LCMV Cl13
and compared the virus-specific CD8
T cell responses at either the initial
stages of infection (day 5) or later during
the response when the exhausted CD8
T cell phenotype first appears (day 10).IL-21 deficiency did not significantly alter IFN-g production
and CD107a expression in CD8 T cells during the initial phase
of Cl13 infection (Figure 1B). Conversely, deletion of IL-21 led
to a significant reduction of IFN-g+CD107a+ CD8 T cells in the
GP33- and NP396-specific effector cells at day 10 p.i. (Fig-
ure 1B). Likewise, granzyme B was rapidly lost by day 10 p.i.
in the absence of IL-21 (Figure 1C). Intriguingly, exacerbated
CD8 T cell exhaustion in Il21/ mice correlated with a signif-
icant reduction of Blimp-1 and BATF expression in effector
CD8 T cells at day 10 but not day 5 p.i., whereas other tran-
scriptional regulators, such as Eomes, T-bet, and IRF4, re-
mained largely unchanged (Figures 1D and S1B). Lastly, we
found that IL-21-induced BATF expression primarily depended
on the signal transducer and activator of transcription 3
(STAT3) signaling pathway (Figure 1E). Together, these data
suggested that the IL-21-STAT3-BATF axis might play a crit-
ical role in the maintenance rather than the establishment of
effector CD8 T cell function and survival.vember 10, 2015 ª2015 The Authors 1119
Figure 2. The Intrinsic Role of BATF in Sus-
taining the Late CD8 Effector Function dur-
ing Chronic Infection
Batf+/+ and Batf/ BM chimeric mice were in-
fected with LCMV Cl13.
(A) The kinetics of LCMV-specific CD8 T cells
(GP33, NP396, and GP276) in the spleen were
determined using major histocompatibility com-
plex tetramer staining at day 5, 8, 14, and 30 p.i.
(n = 4–5 mice per time point).
(B) The representative dot plots are shown for the
frequency of LCMV-specific CD8 T cells in the
spleen from Batf+/+ and Batf/ bone chimeric
mice with indicated LCMV epitopes at day 8 p.i.
(C) At day 8 following LCMV Cl13 infection, sple-
nocytes from both groups were stimulated in vitro
with GP33, NP396, and GP276 peptides. The
representative dot plots show the frequency of
IFN-g-producing CD8 T cells.
(D) The expression of granzyme B was examined
on Batf+/+ (filled gray) and Batf/ (black line)
LCMV-specific CD8 T cells and shown in the
representative histogram. MFI (mean ± SEM) is
shown in the top-left corner.
(E and F) Bar graphs show the expression of
inhibitory molecules (PD-1, 2B4, LAG-3, and
CD160) and transcription factors (Blimp-1, IRF4,
and BATF) on LCMV-specific CD8 T cells.
(G) The viral titers were measured in the serum
samples from Batf+/+ and Batf/mice at day 5, 8,
and 21 p.i. and plotted in the bar graphs. Data are
representative of two independent experiments
(n = 5 for Batf+/+ and n = 5 for Batf/). Data are
presented as mean ± SEM.BATF Is Intrinsically Required for Sustained Effector
Function in CD8 T Cells
To investigate the cell autonomous role of BATF in effector T cell
differentiation, we first generated bone marrow (BM) chimeric
mice with CD8 T cell-specific Batf deletion. In this model, CD8
T cells were reconstituted solely from either wild-type (WT) or
Batf/ BM cells, whereas most other immune cells were WT
(Figure S2). Next, we infected these chimeric mice with LCMV
Cl13 and examined the virus-specific CD8 T cell responses.
Early during infection (day 5), the expansion, effector function
(production of IFN-g and granzyme B), inhibitory molecule, and
transcription factor expression of virus-specific CD8 T cells in
Batf/ chimeric mice were largely indistinguishable from those
in Batf+/+ control cells (Figures S3A–S3F). This led to the similar
viral loads in these two groups of mice (Figure S3G). In contrast,
the frequency and number of GP33, NP396, and GP276
tetramer+ CD8 T cells were drastically reduced in Batf/ BM
chimeric mice by day 8 p.i. and through the later phases of infec-1120 Cell Reports 13, 1118–1124, November 10, 2015 ª2015 The Authorstion in comparison with their WT counter-
parts (Figures 2A and 2B). Likewise, IFN-
g-producing virus-specific CD8 T cells
were significantly reduced in the absence
of BATF (Figure 2C).Batf/ virus-specific
CD8 T cells also expressed significantly
lower amounts of granzyme B and the
inhibitory molecules PD-1 and 2B4, aswell as the transcription factor Blimp-1 (Figures 2D–2F). Lastly,
these impaired effector T cell responses were accompanied by
poor viral containment in Batf/ BM chimeric mice (Figure 2G).
Overall, these data demonstrated that cell-intrinsic BATF
expression was critically required for the maintenance of virus-
specific CD8 T cell effector function and survival at late stages
of chronic viral infection.
BATF Overexpression Enhances CD8 T Cell Response
To explore whether BATF was sufficient to augment effector
function, the MSCV-IRES-Thy1.1 (MIT) retroviral vector (RV)
was used to overexpress BATF in CD8 T cells, with transduced
cells identified by Thy1.1 expression. To facilitate the detection,
we used CD8 T cells from P14 T cell receptor (LCMV GP33-
specific) transgenic mice as donor cells. Most P14 cells trans-
duced with empty MIT RV underwent contraction from day
8–21 p.i., whereas P14 cells transduced with BATF-MIT RV
significantly increased in frequency over time (Figure 3A). To
Figure 3. Overexpressing BATF Can
Improve the Quality and Quantity of CD8 T
Cells during Chronic Infection
(A–G) C57BL/6 mice contained P14 cells trans-
duced with either MIT or BATF-MIT RV were in-
fected with LCMV Cl13. (A) The frequency of
positively transduced (Thy1.1+) P14 cells was
examined in the peripheral blood on day 8 and 21
p.i. and plotted in line graphs. (B) At day 21 p.i., the
splenic Thy1.1+ RV-transduced P14 cells were
examined for the expression of Ki67 and shown by
representative histograms and bar graphs. (C)
Representative dot plots (left) are shown for the
staining of Annexin-V and 7-AAD on Thy1.1+ RV-
transduced P14 cells at day 21 p.i. The frequencies
of live cells (Annexin-V7-AAD), apoptotic cells
(Annexin-V+7-AAD), and dead cells (7-AAD+) are
shown in the bar graphs (right). (D) Dot plots show
the proportion of Thy1.1+ cells among the CD107a
and IFN-g double-positive populations following
in vitro GP33 stimulation. (E and F) Histograms
show the expression of granzyme B and Blimp-1 in
the splenic Thy1.1+ RV-transduced P14 cells on
day 21 p.i. (G) Bar graphs show the viral titers in the
serum samples on day 8 and 21 p.i.
(H–J) C57BL/6 mice contained P14 cells trans-
duced with either MIT or BATF-MIT RV were CD4
depleted and infected with LCMV Cl13. (H) The
expression of BATF was examined in LCMV-spe-
cific CD8 T cells from control untreated or CD4-
depleted B6 mice on day 21 p.i. and are shown by
representative histograms and bar graphs. (I) The
frequency of Thy1.1+ RV-transduced P14 cells was
examined in peripheral blood at day 8 and 21 p.i.
and plotted in line graphs. (J) Bar graphs show the
viral titers in the serum samples at day 8 and 21 p.i.
(K–L) C57BL/6 mice contained Il21r/ P14 cells
transduced with either MIT or BATF-MIT RV were
infected with LCMV Cl13. (K) The frequency of
Thy1.1+ RV-transduced P14 cells was examined in
peripheral blood at day 8 and 21 p.i. and plotted in
line graphs. (L) Bar graphs show the viral titers in
the serum samples at day 8 and 21 p.i. Results are
representative of three independent experiments
with six mice in total per group. Data are presented
as mean ± SEM.dissect whether BATF-mediated enrichment of P14 cells at
the later stages of infection resulted from increased expan-
sion or survival, we assessed the proliferation and apoptosis
of Thy1.1+ RV-transduced cells. BATF-overexpressing cells
(BATF-Thy1.1+) contained a significantly higher proportion of
proliferating cells (Ki67+) and had increased survival (Annexin-
V7-AAD [7-amino-actinomycin D]) compared with empty
MIT-transduced cells (control-Thy1.1+) (Figures 3B and 3C).
In addition, BATF overexpression clearly increased the fre-
quency of CD107a+ and IFN-g+ cells in total transferred P14
cells compared to empty MIT at day 21 p.i. (Figure 3D). Further-
more, BATF overexpression led to higher expression of gran-
zyme B and Blimp-1 (Figures 3E and 3F) and better viral control
(Figure 3G). Collectively, these data suggest that BATF
enhanced both the quantity and the quality of virus-specific
CD8 T cells.Cell RepBATF Overexpression Rescues ‘‘Unhelped’’ CD8 T Cells
Given that CD4 T cells are the main producers of IL-21, BATF
expression in GP33-specific effector CD8 T cells was signifi-
cantly reduced in the absence of CD4 cells (Figure 3H). Next,
we examined whether BATF overexpression could restore the
effector function of virus-specific CD8 T cells in the absence of
CD4 help. Consistent with the preceding observations, BATF
overexpression significantly enhanced the expansion, survival,
and effector function of P14 cells in comparison with control
MIT RV-transduced cells (Figure 3I and data not shown). These
heightened CD8 T cell responses mediated by BATF overex-
pression led to significantly improved viral control (Figure 3J).
Similar observations were obtained in IL-21 receptor (IL-21R)-
deficient CD8 T cells when BATF was overexpressed in Il21r/
P14 cells (Figures 3K and 3L). Collectively, these results sug-
gested that BATF overexpression could bypass the requirementorts 13, 1118–1124, November 10, 2015 ª2015 The Authors 1121
Figure 4. IL-21-Induced BATF Expression
and Antigen-Regulated IRF4 Cooperate to
Sustain the Effector Function
(A and B) CD8 T cells from Batf+/+ and Batf/
mice were cultured in IL-2hi (10 ng/ml; A) or IL-2lo
(1 ng/ml; B) conditions and were treated by IL-21.
The protein level of Blimp-1, IRF4, and BATF was
examined by western blot and quantified using
ImageQuant (Amersham). The relative intensities
of Blimp-1, IRF4, and BATF to GRP94 (loading
control) were calculated and indicated below the
blots.
(C–E) IL-21 was supplemented in IL-2lo-skewed
CD8 T cells for 2 days. (C) Numbers in the dot plots
show the frequency of IFN-g+CD107a+ CD8 T cells
after in vitro GP33 stimulation. (D and E) The
expression of granzyme B and transcriptional
factors (Blimp-1, IRF4, and BATF) is shown in
histograms.
(F) The IL-2lo cells were cultured for 3 days and
followed by stimulation with anti-CD3 or IL-21
alone or in combination. Western blots show the
protein level of Blimp-1, IRF4, and BATF relative to
GRP94. Results are representative of three inde-
pendent experiments.for CD4 help and IL-21 signaling in the maintenance of effector
CD8 T cell responses during chronic viral infection.
BATF and IRF4 Cooperatively Regulate Blimp-1
Expression
Recent studies have elegantly demonstrated that BATF and IRF4
cooperatively bind to AP1-IRF4 composite elements (AICEs),
and contribute to the chromatin accessibility of a set of line-
age-specific genes that regulate Th17 and CD8 T cell develop-
ment (Ciofani et al., 2012; Kurachi et al., 2014; Li et al., 2012;
Murphy et al., 2013; Schraml et al., 2009). In agreement with
these observations, we found that IRF4 was also intrinsically
required for CD8 T cell differentiation and antiviral function dur-
ing chronic LCMV infection (Figure S4). Analyzing the chromatin
immunoprecipitation sequencing datasets obtained from both
CD4 and CD8 T cells (Kurachi et al., 2014; Li et al., 2012), we
identified AICEs in multiple genes associated with late effector
CD8 T cell differentiation, metabolism, and function, such as1122 Cell Reports 13, 1118–1124, November 10, 2015 ª2015 The AuthorsPrdm1, Tbx21, Hif1a, and Gzmb (data
not shown). Given the crucial role of
Blimp-1 (encoded by Prdm1) in maintain-
ing effector function in virus-specific CD8
T cells, we tested how Blimp-1 expres-
sion was regulated by the cooperative
activity of BATF and IRF4. First, we estab-
lished an in vitro effector T cell differentia-
tion model to mimic the cytokine environ-
ment at early (high IL-2 [IL-2hi], low IL-21)
and later (low IL-2 [IL-2lo], high IL-21)
phases of effector T cell differentiation
during chronic infection in vivo. Under
IL-2hi culture conditions, CD8 T cells
maintained Blimp-1 expression as re-ported previously (Figure 4A) (Pipkin et al., 2010) and IL-21
was able to further augment Blimp-1 (Figure 4A). Conversely,
in IL-2lo culture conditions, Blimp-1 expression was largely
diminished, although BATF and IRF4 were still modestly ex-
pressed (Figure 4B). IL-21 induced Blimp-1 expression in IL-
2lo-skewed CD8 T cells, which was accompanied by strong
BATF induction (Figure 4B). However, this IL-21-induced
Blimp-1 expression was diminished in Batf/ CD8 T cells (Fig-
ure 4B). We further observed that IL-21 supplementation in
IL-2lo-cultured CD8 T cells sustained IFN-g production, degran-
ulation (i.e., CD107a expression), and granzyme B expression
(Figures 4C and 4D), which was accompanied by elevated
BATF and Blimp-1 expression (Figure 4E). Thus, BATF-depen-
dent induction of Blimp-1 by IL-21 that occurs in IL-2lo environ-
ments is crucial for sustained effector function in CD8 T cells.
Given that decreased Blimp-1 expression was also found in
IRF4-deficient CD8 T cells (Figure S4F), we next directly exam-
ined whether BATF might need to cooperate with IRF4 to
regulate Blimp-1 expression. To test this idea, we skewed acti-
vated CD8 T cells in IL-2lo culture for a longer time (3 days) until
IRF4 expression wasmostly diminished (Figure 4F). Even though
IL-21 promoted BATF expression (Figure 4F) and antigen stimu-
lation (anti-CD3 antibody) induced IRF4 expression as reported
previously (Man et al., 2013; Yao et al., 2013), either stimulus
alone failed to potently induce Blimp-1 expression (Figure 4F).
Only when BATF and IRF4 were simultaneously induced by
combined IL-21 and antigen treatment was Blimp-1 expression
strongly upregulated (Figure 4F). Collectively, these results sug-
gest that IL-21 and antigen transcriptionally synergize, by the
respective induction of BATF and IRF4, to maintain Blimp-1
expression and CD8 T cell effector function.
DISCUSSION
In this study, we identified a pathway that connects CD4-derived
IL-21 to a BATF-mediated transcriptional program in CD8 T cells,
which plays a key role in the maintenance of the effector CD8
T cell response. Moreover, the IL-21-STAT3-BATF pathway is
likely the molecular mechanism of CD4 help during chronic viral
infection, because BATF overexpression could rescue unhelped
CD8 T cell function during chronic viral infection. Finally, we
found that the transcriptional partner of BATF, IRF4, was criti-
cally required for the sustained expression of Blimp-1, as well
as themaintenance and function of effector T cells. These results
unexpectedly reveal that CD4 help (via IL-21-BATF) may syner-
gize with antigen engagement (via TCR-IRF4) to maintain the
CD8 T cell response during chronic infection.
In response to persistent viral infection, CD4 T cells become
dysfunctional asmeasured by a diminished ability to co-produce
cytokines such as IFN-g, TNF-a, and IL-2 (Brooks et al., 2005;
Crawford et al., 2014; Fuller and Zajac, 2003; Oxenius et al.,
1998). Interestingly, these exhausted CD4 T cells gradually
gain the ability to produce other cytokines, such as IL-21 (Fahey
et al., 2011; Harker et al., 2011, 2013). This developmental tran-
sition may alter the helper functions of CD4 T cells to enable in-
fected hosts to better adapt to chronic viruses. The immune
response to a chronic infection must balance anti-viral function
such that the infection is contained without causing fatal immu-
nopathology. Changes in the cytokine environment, including
changes in the cytokine profile of CD4 T cells, likely play an
important role in keeping this balance. Furthermore, a switch
from IL-2 to IL-21 production during chronic infection appears
to sustain sufficiently low levels of effector function for viral con-
trol without immunopathology. This notion has been supported
by recent studies in which IL-21 as a pleiotropic cytokine pro-
motes follicular helper T and B cell differentiation and anti-
body-mediated viral containment in the late phase of chronic
viral infection (Fahey et al., 2011; Harker et al., 2011; Petrovas
et al., 2012).
BATF, lacking a transcription activation domain, was initially
considered as a dominant-negative regulator of activator protein
1 activity (Echlin et al., 2000; Murphy et al., 2013). However,
recent discoveries unveiled that BATF-JUN heterodimers
interact with IRF4 to cooperatively bind to compound-binding
cis-regulatory elements of a distinct subset of target genes,
which activate transcriptional networks that govern Th17 cell dif-Cell Repferentiation (Ciofani et al., 2012; Li et al., 2012; Murphy et al.,
2013; Schraml et al., 2009). BATF was also recently shown to
regulate effector CD8 T cell metabolism and survival (Kurachi
et al., 2014), which may explain the survival deficiencies we
see inBatf-deficient CD8 T cells during chronic infection. Despite
the essential function of BATF in the development of a range of
immune cells, little is known about howBATF expression is regu-
lated. Here, we identified IL-21 as a positive signal that regulates
BATF expression in CD8 T cells through a STAT3-dependent
pathway. This raises the question of whether other STAT3 cyto-
kines elevated during the later phases of LCMV Cl13 infection,
such as IL-10, IL-27, and IL-6, can also induce BATF expression
in CD8 T cells. In addition, other signals, such as IL-12 and PD-1
ligation, can induce BATF expression in CD8 T cells (Kuroda
et al., 2011; Quigley et al., 2010). The relative contribution of




C57BL/6, Cd8a/, and Batf/ mice were purchased from Jackson Labora-
tory. Il21/ mice were purchased from Taconic. Mouse handling conformed
to the requirements of the Institutional Animal Care and Use Guidelines of
Medical College of Wisconsin.
Flow Cytometry
Lymphocytes harvested from spleen and other organs were stained and
analyzed by flow cytometry. All antibodies were purchased from eBioscience
and BD Biosciences except anti-granzyme B phycoerythrin (Invitrogen), BATF
(Cell Signaling Technology), and mouse IL-21 receptor Fc (R&D Systems). All
flow cytometry data were acquired on an LSR II (BDBiosciences) and analyzed
by FlowJo (Tree Star).
Retrovirus-Mediated BATF Overexpression
MIT RV was obtained from Dr. Susan Kaech. BATF was subcloned into MIT to
generate the BATF-MIT vector. To overexpress BATF in P14 cells, the spin
transfection method was used as described previously (Kao et al., 2011).
Statistical Analysis
Student’s t tests were performed by using the GraphPad Prism 6.0 software.
*p < 0.05, **p < 0.01 in all data shown.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures
and four figures and can be found with this article online at http://dx.doi.org/
10.1016/j.celrep.2015.09.069.
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